Delorean Raises $750K in Share Purchase Plan for Bioenergy Projects
Delorean Corporation has closed its Share Purchase Plan, raising $750,000 through the issue of over 8.3 million shares at $0.09 each, supplementing earlier strategic funding from LMS Energy.
- SPP raised $750,000, below $2.2 million target
- Issued 8.33 million shares at $0.09 each
- Funds complement prior LMS Energy placement
- No immediate plans for further share issuance
- Supports ongoing bioenergy infrastructure projects
Share Purchase Plan Closes with $750,000 Raised
Delorean Corporation (ASX:DEL) has wrapped up its Share Purchase Plan (SPP), generating $750,000 through the issuance of 8,333,405 new shares priced at $0.09 each. This capital raise followed a strategic placement to LMS Energy at the same price, aiming to give existing shareholders a chance to participate on equal terms.
The SPP initially targeted $2.2 million, matching the value of the LMS Energy placement, but closed with a smaller subscription. The company has confirmed there are no immediate intentions to issue further shares to bridge the shortfall, leaving some questions about future funding strategies.
Capital Raise Supports Key Bioenergy Projects
This fresh injection of capital adds to Delorean’s war chest as it advances its bioenergy infrastructure pipeline. The company remains focused on projects like the SA1 Salisbury facility, which is currently 75% complete and slated to inject renewable biomethane into Adelaide’s gas network by November 2026, a first for commercial organic waste processing in Australia. The SPP proceeds will help underpin these developments, alongside the NSW1 Horsley Park bioenergy facility, which recently reached a positive Final Investment Decision backed by substantial government grants. These projects collectively position Delorean at the forefront of renewable energy and waste management sectors.
Delorean’s vertically integrated model spans engineering, infrastructure, and energy retail divisions, allowing it to capture multiple revenue streams from waste processing and renewable energy sales. This strategy is critical as the company scales its operations across South Australia and New South Wales, leveraging government incentives and strategic partnerships to accelerate growth.
Share Issuance Timeline and Market Impact
The new shares from the SPP are expected to be issued on 29 May 2026, with trading commencing on 1 June 2026. Investors will be watching how the market absorbs this increase in share capital, especially given the smaller-than-anticipated raise compared to the $2.2 million cap. The company’s ability to fund its ambitious project pipeline without immediate further dilution may provide some reassurance, but the shortfall leaves open questions about longer-term capital needs.
Delorean’s recent receipt of a $5.76 million R&D tax refund has bolstered its cash position, complementing the equity raised and supporting ongoing project development. The combined effect of these funding sources will be critical as Delorean navigates the transition from construction to operational phases of its bioenergy assets.
Bottom Line?
Delorean’s modest SPP raise strengthens its balance sheet but leaves open questions on funding the gap to earlier targets amid ambitious project timelines.
Questions in the middle?
- Will Delorean pursue further capital raises to reach the original $2.2 million SPP target?
- How will the market respond to the increased share count when trading resumes in June?
- What are the next funding milestones for the NSW1 Horsley Park bioenergy facility?
